| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:DA-3934
CAS:183176-50-3
Package:50mg/RMB 19800;100mg/RMB 25500;25mg/RMB 15000
|
Glycinamide, N-[[[3-(carboxymethyl)phenyl]amino]carbonyl]glycyl-N-methyl-N2-[2-[2-(methylphenylamino)-2-oxoethoxy]phenyl]-N-phenyl- (9CI) manufacturers
- DA-3934
-
- $2780.00
-
2026-05-11
- CAS:183176-50-3
- Purity:
- Supply Ability: 10g
|
| | Glycinamide, N-[[[3-(carboxymethyl)phenyl]amino]carbonyl]glycyl-N-methyl-N2-[2-[2-(methylphenylamino)-2-oxoethoxy]phenyl]-N-phenyl- (9CI) Basic information |
| | Glycinamide, N-[[[3-(carboxymethyl)phenyl]amino]carbonyl]glycyl-N-methyl-N2-[2-[2-(methylphenylamino)-2-oxoethoxy]phenyl]-N-phenyl- (9CI) Chemical Properties |
| Boiling point | 835.8±65.0 °C(Predicted) | | density | 1.354±0.06 g/cm3(Predicted) | | pka | 4.22±0.10(Predicted) |
| | Glycinamide, N-[[[3-(carboxymethyl)phenyl]amino]carbonyl]glycyl-N-methyl-N2-[2-[2-(methylphenylamino)-2-oxoethoxy]phenyl]-N-phenyl- (9CI) Usage And Synthesis |
| Uses | DA-3934 is a cholecystokinin (CCK)-B receptor antagonist. DA-3934 inhibits Pentagastrin (HY-A0261)-induced gastric acid secretion in rats[1]. | | References | [1] Takeda Y, et al. Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. II. Chem Pharm Bull (Tokyo). 1998 Jun;46(6):951-61. DOI:10.1248/cpb.46.951 |
| | Glycinamide, N-[[[3-(carboxymethyl)phenyl]amino]carbonyl]glycyl-N-methyl-N2-[2-[2-(methylphenylamino)-2-oxoethoxy]phenyl]-N-phenyl- (9CI) Preparation Products And Raw materials |
|